English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusRecruiting
Sponsors
Memorial Sloan Kettering Cancer Center
Collaborators
American Cancer Society, Inc.

Keywords

Abstract

The purpose of this study is to find out what effects, if any, exercise and a plant-based diet have on aromatase levels in postmenopausal women who are overweight and being treated with an aromatase inhibitor for their HR+, HER2- breast cancer. The study will also look at other ways diet and exercise may affect your body (for example, changing the way your breast tissue expresses or makes genes) and your quality of life.

Dates

Last Verified: 03/31/2020
First Submitted: 03/03/2020
Estimated Enrollment Submitted: 03/03/2020
First Posted: 03/05/2020
Last Update Submitted: 04/01/2020
Last Update Posted: 04/05/2020
Actual Study Start Date: 03/03/2020
Estimated Primary Completion Date: 02/28/2022
Estimated Study Completion Date: 02/28/2022

Condition or disease

Breast Cancer
Primary Hormone Receptor Positive Breast Cancer

Intervention/treatment

Other: Exercise Treatment and Plant-Based Diet

Other: Exercise Treatment and Plant-Based Diet

Other: Physical activity and nutrition counseling

Other: Physical activity and nutrition counseling

Phase

Phase 2

Arm Groups

ArmIntervention/treatment
Experimental: Exercise Treatment and Plant-Based Diet
Will consist of structured exercise treatment plus a calorie-restricted plant-based diet. Exercise treatment will consist of individualized walking delivered up to 7 times weekly to achieve the patient-specific goal energy expenditure. Training sessions will be performed at MSK or on a treadmill under remote surveillance using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service. Pre-prepared meals, including 6 dinners and 6 lunches per week, will be shipped to the partipant's home during the intervention.
Other: Exercise Treatment and Plant-Based Diet
Exercise treatment will consist of individualized walking delivered up to 7 times weekly to achieve the patient-specific goal energy expenditure. Training sessions will be performed on a treadmill at MSK or under remote surveillance using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service.
Active Comparator: Physical activity and nutrition counseling
Will consist of a general physical activity and nutrition program including regular counseling by exercise physiologists and registered dieticians. Treadmills and low-calorie recipes will be provided to patients in the counseling arm.
Other: Physical activity and nutrition counseling
Treadmills and low-calorie recipes will be provided to patients in the counseling arm.

Eligibility Criteria

Ages Eligible for Study 18 Years To 18 Years
Sexes Eligible for StudyFemale
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria:

- Patients with histologically-confirmed, HR-positive (ER and/or PR), HER2-negative stage 1-3 breast cancer

- Postmenopausal status defined by lack of menses for 2 years, oophorectomy, or medical ovarian suppression

- At least 3 months post completion of chemotherapy, if administered

- At least 3 months post radiation, if administered

- Receiving adjuvant endocrine therapy with an aromatase inhibitor (anastrozole, letrozole, exemestane)

- ECOG performance status of 0 to 1

- Sedentary (i.e., <150 minutes / week of exercise)

- Age ≥ 18

- BMI ≥ 27

- Able to achieve an acceptable peak baseline CPET, as defined by any of the following criteria and in the absence of high risk ECG findings or other inappropriate response to exercise as determined by the investigator:

- Achieved a plateau in oxygen consumption, concurrent with an increase in power output

- A respiratory exchange ratio ≥ 1.10

- Attainment of maximal predicted heart rate (HRmax) (i.e., within10 bpm of age- predicted HRmax [HRmax= 220 - Age (years)]

- Volitional exhaustion, as measured by a rating of perceived exertion (RPE) ≥ 18 on the BORG scale.

- Willingness to comply with all study-related procedures

- Intact breast available for biopsy

Exclusion Criteria:

- Presence of metastatic disease

- Insulin-dependent diabetes mellitus or non-insulin dependent diabetes mellitus on medical therapy

- Enrollment onto any other therapeutic investigational study

- Mental impairment leading to inability to cooperate

- Any of the following contraindications to exercise:

1. Acute myocardial infarction within 3-5 days of any planned study procedures;

2. Unstable angina

3. Uncontrolled arrhythmia causing symptoms or hemodynamic compromise

4. Recurrent syncope

5. Active endocarditis

6. Acute myocarditis or pericarditis

7. Symptomatic severe aortic stenosis

8. Uncontrolled heart failure

9. Acute pulmonary embolus or pulmonary infarction within 3 months of any planned study procedures

10. Thrombosis of lower extremities

11. Suspected dissecting aneurysm

12. Uncontrolled asthma

13. Pulmonary edema

14. Respiratory failure

15. Acute non-cardiopulmonary disorders that may affect exercise performance

- Any other condition or intercurrent illness that, in the opinion of the investigator, makes the subject a poor candidate for study participation.

- Nut or legume allergy

- Concurrent participation in weight loss or other exercise programs

Outcome

Primary Outcome Measures

1. change in breast aromatase levels [24 weeks post-intervention]

Will explore the data using descriptive statistics and graphical methods, such as summarizing the aromatase levels at baseline and at 24 weeks using means and medians and plotting the data to visualize changes over time. To compare the aromatase levels at 24 weeks post-intervention between the groups, an analysis of covariance (ANCOVA) model will be used.

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge